Transcriptomic analysis demonstrated that MMP2, MMP7, MMP16, MMP19, MMP23, and MMP28 were significantly upregulated in both male and female NSCLC patients with elevated tumoral GHR expression. Here, MMP2 is linked to non-small cell lung carcinoma.